KLRA
KLRA
US4829311020
Kailera Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
158.340.000 --
--
Operating Income -158.340.000 --
--
Pretax Income -148.955.000 --
--
Net Income Common Stockholders -148.955.000 --
--
-- --
--
-- --
--
ende